🇺🇸 Digoxin tablet in United States

21 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Somnolence — 3 reports (14.29%)
  2. Anaemia — 2 reports (9.52%)
  3. Atrial Fibrillation — 2 reports (9.52%)
  4. Cardiac Failure — 2 reports (9.52%)
  5. Dyspnoea — 2 reports (9.52%)
  6. Fall — 2 reports (9.52%)
  7. Hypotension — 2 reports (9.52%)
  8. Hypoventilation — 2 reports (9.52%)
  9. Hypoxia — 2 reports (9.52%)
  10. Multi-Organ Failure — 2 reports (9.52%)

Source database →

Digoxin tablet in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Digoxin tablet approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Digoxin tablet in United States?

Jiangsu HengRui Medicine Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.